1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Du, Zhiyong ^a,b   Shen, Anna ^a   Huang, Yuli ^a   Su, Liang ^a,b   Lai, Wenyan ^a,b   Wang, Peng ^a,b   Xie, Zhibing ^a,b   Xie, Zhiquan ^c   Zeng, Qingchun ^a,b   Ren, Hao ^a,b   Xu, Dingli ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SUCCINIC ACID;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; CARR PURCELL MELBOOM GILL PULSE SEQUENCE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ENERGY EXPENDITURE; EQUIPMENT DESIGN; FEMALE; HEART FAILURE; HEART MUSCLE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROMETER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTIAL LEAST SQUARES REGRESSION; PHYSICAL PHENOMENA; PROTON NUCLEAR MAGNETIC RESONANCE; PULSE GENERATOR; SIGNAL DETECTION; STATISTICAL MODEL; SYSTEM ANALYSIS; UPREGULATION; VERY ELDERLY;

3-HYDROXYBUTYRIC ACID; ACETONE; ADULT; AGED; AGED, 80 AND OVER; ENERGY METABOLISM; FEMALE; HEART FAILURE; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; MYOCARDIUM; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SERUM; SUCCINIC ACID;

EID: 84895560867     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088102     Document Type: Article

References (31)

1. van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ (2009) Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovasc Res 81: 420-428.
2. Neubauer S (2007) The failing heart-an engine out of fuel. N Engl J Med 356: 1140-1151.
3. Mudd JO, Kass DA (2008) Tackling heart failure in the twenty-first century. Nature 451: 919-928. (Pubitemid 351301747)
4. Palmieri V, Roman MJ, Bella JN, Liu JE, Best LG, et al. (2008) Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart Study. J Am Soc Echocardiogr 21: 66-71.
5. Shah SH, Kraus WE, Newgard CB (2012) Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 126: 1110-1120.
6. Rhee EP, Gerszten RE (2012) Metabolomics and cardiovascular biomarker discovery. Clin Chem 58: 139-147.
7. Kaddurah-Daouk R, Krishnan KR (2009) Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 34: 173-186.
8. O'Hagan S, Dunn WB, Knowles JD, Broadhurst D, Williams R, et al. (2007) Closed-loop, multiobjective optimization of two-dimensional gas chromatography/mass spectrometry for serum metabolomics. Anal Chem 79: 464-476. (Pubitemid 46106111)
9. Kang SM, Park JC, Shin MJ, Lee H, Oh J, et al. (2011) (1)H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure. Clin Biochem 44: 293-299.
10. Tenori L, Hu X, Pantaleo P, Alterini B, Castelli G, et al. (2013) Metabolomic fingerprint of heart failure in humans: a nuclear magnetic resonance spectroscopy analysis. Int J Cardiol 168:e113-135.
11. Palmieri V, Bella JN, Arnett DK, Oberman A, Kitzman DW, et al. (2003) Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: the Hypertension Genetic Epidemiology Network study. Am Heart J 145: 1071-1077. (Pubitemid 36688260)
12. Beckwith-Hall BM, Brindle JT, Barton RH, Coen M, Holmes E, et al. (2002) Application of orthogonal signal correction to minimise the effects of physical and biological variation in high resolution 1H NMR spectra of biofluids. Analyst 127: 1283-1288. (Pubitemid 35216891)
13. Gavaghan CL, Wilson ID, Nicholson JK (2002) Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS letters 530: 191-196. (Pubitemid 35248210)
14. Kim SH, Yang SO, Kim HS, Kim Y, Park T, et al. (2009) 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet. Anal Bioanal Chem 395: 1117-1124.
15. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC (1995) 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 67: 793-811.
16. Foxall PJ, Parkinson JA, Sadler IH, Lindon JC, Nicholson JK (1993) Analysis of biological fluids using 600 MHz proton NMR spectroscopy: application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment. J Pharm Biomed Anal 11: 21-31. (Pubitemid 23085144)
17. Turer AT, Stevens RD, Bain JR, Muehlbauer MJ, van der Westhuizen J, et al. (2009) Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation 119: 1736-1746.
18. Nagoshi T, Yoshimura M, Rosano GM, Lopaschuk GD, Mochizuki S (2011) Optimization of cardiac metabolism in heart failure. Curr Pharm Des 17: 3846-3853.
19. Aquilani R, Opasich C, Verri M, Boschi F, Febo O, et al. (2003) Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 42: 1218-1223. (Pubitemid 37188345)
20. Shen AN, Du ZY, Wang P, Xie ZB, Xu DL (2010) [Value of Doppler echocardiography derived myocardial energy expenditure measurements in chronic heart failure patients]. Zhonghua Xin Xue Guan Bing Za Zhi 38: 209-214.
21. Liang J, Bai S, Xu D, Cheng Z (2012) [Effect of different doses of perindopril on myocardial energy expenditure in patients with heart failure following myocardial infarction]. Nan Fang Yi Ke Da Xue Xue Bao 32: 1816-1819, 1832.
22. Avogaro A, Nosadini R, Doria A, Fioretto P, Velussi M, et al. (1990) Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol 258: E606-E618. (Pubitemid 20142341)
23. Hall JL, Stanley WC, Lopaschuk GD, Wisneski JA, Pizzurro RD, et al. (1996) Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol 271: H2320-H2329.
24. Lommi J, Kupari M, Koskinen P, Naveri H, Leinonen H, et al. (1996) Blood ketone bodies in congestive heart failure. J Am Coll Cardiol 28: 665-672. (Pubitemid 26288648)
25. Lommi J, Koskinen P, Naveri H, Harkonen M, Kupari M (1997) Heart failure ketosis. J Intern Med 242: 231-238. (Pubitemid 27400436)
26. Forsey RG, Reid K, Brosnan JT (1987) Competition between fatty acids and carbohydrate or ketone bodies as metabolic fuels for the isolated perfused heart. Can J Physiol Pharmacol 65: 401-406. (Pubitemid 17068315)
27. Chen V, Wagner G, Spitzer JJ (1984) Regulation of substrate oxidation in isolated myocardial cells by beta-hydroxybutyrate. Horm Metab Res 16: 243-247. (Pubitemid 14102222)
28. Kerbey AL, Randle PJ, Cooper RH, Whitehouse S, Pask HT, et al. (1976) Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A and reduced and oxidized nicotinamide-adenine dinucleotide. Biochem J 154: 327-348.
29. Kunau WH, Dommes V, Schulz H (1995) beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res 34: 267-342.
30. Pisarenko O, Studneva I, Khlopkov V (1987) Metabolism of the tricarboxylic acid cycle intermediates and related amino acids in ischemic guinea pig heart. Biomed Biochim Acta 46: S568-S571.
31. Davili Z, Johar S, Hughes C, Kveselis D, Hoo J (2007) Succinate dehydrogenase deficiency associated with dilated cardiomyopathy and ventricular noncompaction. Eur J Pediatr 166: 867-870. (Pubitemid 46988165)